01 Sep 2020 Elixirgen Therapeutics planning to begin Phase I/II Clinical Trials of its COVID-19 Vaccine Candidate EXG-5003 at Fujita Health University
01 Sep 2020 HDT BIO Receives NIH Contract to Advance Novel RNA/LION™ COVID-19 Vaccine Into Clinical Trials
01 Sep 2020 Aegis Life, Inc. Launches to Fight COVID-19 via DNA Vaccines and Therapeutics Enabled by Proprietary Fusogenix Delivery Technology
01 Sep 2020 Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups
31 Aug 2020 Daiichi Sankyo Selected for AMED’s “Development of a Vaccine for COVID-19 Vaccines (Second Round)”
28 Aug 2020 Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results
27 Aug 2020 GSK announces first participant vaccinated in phase 3 clinical trials of its 5-in-1, meningitis ABCWY vaccine candidate
26 Aug 2020 VBI Vaccines Announces Preclinical Coronavirus Program Data and Selection of Clinical Candidates with Potential as One-Dose Vaccines
26 Aug 2020 EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics
25 Aug 2020 Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine
25 Aug 2020 Intravacc and Therapyx jointly develop the world's first prophylactic gonorrhea vaccine
24 Aug 2020 Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
24 Aug 2020 ReiThera's COVID-19 Vaccine Candidate Enters Phase 1 Clinical Study with First Healthy Volunteer Dosed in Italy
21 Aug 2020 TechnoVax and CUNY Med School Report COVID-19 Vaccine Breakthrough
21 Aug 2020 Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
20 Aug 2020 CureVac and European Commission in Advanced Discussions to Supply up to 405 million doses of potential mRNA-based COVID-19 Vaccine
19 Aug 2020 Lymph Node Targeting COVID-19 Vaccine Induces Up To 25-Fold More T Cells Over Benchmark Vaccines and >265-Fold Greater Antibody Levels Than Recovering Patients
19 Aug 2020 ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 in Recurrent Glioblastoma Patients
18 Aug 2020 Intravacc's candidate RSV vaccine demonstrates safety in phase I trial
17 Aug 2020 Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers
17 Aug 2020 OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With Multi-Target Vaccine CoVepiT
17 Aug 2020 Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
14 Aug 2020 AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine
13 Aug 2020 Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies
12 Aug 2020 Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in a Phase 1/2a Study Arm Evaluating VB10.NEO, a Personalized Neoantigen Cancer Vaccine, with Bempegaldesleukin (NKTR-214) in Patients with Squamous Cell Carcinoma of the Head and Neck

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up